Prothix BV - Company Review
Prothix BV - Company ReviewSummary
Prothix BV (Prothix) is a biopharmaceutical company that develops protein therapeutics for inflammation and coagulation disorders. The company develops monoclonal antibody products. Its products are developed along a trajectory, which includes humanization and deimmunization, generation of manufacturing cell-lines, and development of a manufacturing process. Prothix’s product portfolio includes PRO-01, PRO-02, PRO-03 and PRO-04. The company’s products are used in the therapeutic areas of thrombo-embolic disorders, ischemia reperfusion damage and antibody-mediated diseases, bleeding disorders, and different forms of angioedema. It collaborates with academic groups and pharma companies to profile its product candidates. Prothix is headquartered in Leiden, The Netherlands.
This comprehensive company report of Prothix BV provides you with company's businesses and operations information.
The profile contains critical company information including,
- Company Overview - A detailed description of the company's operations and business divisions.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
GlobalData is a one-stop solution for actionable insight into the pharmaceutical and medical device sectors. Together with the best team of researchers, analysts, epidemiologists and consultants, and an unmatched suite of proprietary databases, we provide high-quality, accurate and transparent insight that can help you achieve growth and increase business value.
Our valuable research and consulting solutions ensure you stay at the forefront of the industry by integrating accurate market forecasts and healthcare analytics on the latest trends and developments. Among other benefits, our informed healthcare industry perspectives have assisted businesses based across the pharmaceuticals, biotechnology and medical equipment markets in making strategic decisions that have increased the value of their products and services.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.